Venrock Healthcare Capital Partners III, L.P., Ten Percent Owner at Constellation Pharmaceuticals, holds 4.82M shares in KalVista Pharmaceuticals (Ticker: KALV), holds 3.50M shares in Altimmune (Ticker: ALT), holds 4.36M shares in Cogent Biosciences (Ticker: COGT). Most recently, Venrock Healthcare Capital Partners III, L.P. Bought ― shares of KalVista Pharmaceuticals on Feb 08, 2024 for an estimated value of 1.26M.